Compare · DNA vs LNZA
DNA vs LNZA
Side-by-side comparison of Ginkgo Bioworks Holdings Inc. (DNA) and LanzaTech Global Inc. (LNZA): market cap, price performance, sector, and recent activity on the wire.
Summary
- DNA operates in Health Care, while LNZA operates in Industrials - the two are in different parts of the market.
- DNA is the larger of the two at $483.6M, about 12.8x LNZA ($37.8M).
- LNZA has been more active in the news (6 items in the past 4 weeks vs 5 for DNA).
- DNA has more recent analyst coverage (18 ratings vs 5 for LNZA).
- Company
- Ginkgo Bioworks Holdings Inc.
- LanzaTech Global Inc.
- Price
- -
- -
- Market cap
- $483.6M
- $37.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 5
- 6
- Recent ratings
- 18
- 5
DNA
Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts.
Latest DNA
- Amendment: SEC Form SCHEDULE 13G/A filed by Ginkgo Bioworks Holdings Inc.
- SEC Form 10-Q filed by Ginkgo Bioworks Holdings Inc.
- Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo
- SEC Form 8-K filed by Ginkgo Bioworks Holdings Inc.
- Officer Coen Steven P. sold $7,770 worth of shares (766 units at $10.14) (SEC Form 4)
- Officer Shetty Reshma P. sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)
- Large owner Canton Barry sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)
- Officer Kelly Jason R sold $463,353 worth of shares (45,682 units at $10.14) (SEC Form 4)
- Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
Latest LNZA
- SEC Form 10-Q filed by LanzaTech Global Inc.
- LanzaTech Global Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- LanzaTech Reports Third Quarter 2026 Financial Results
- Large owner Khosla Vinod acquired 1,737,921 warrants (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by LanzaTech Global Inc.
- LanzaTech Announces Date for Third Quarter 2026 Earnings Release and Conference Call
- Hebei Shoulang Facility Using LanzaTech Technology Achieves World’s First ISCC EU RCF Certification for Ethanol Produced from Steel Mill Waste Gases
- SEC Form 8-K filed by LanzaTech Global Inc.
- LanzaJet Secures Financing to Scale SAF Production and Supply Global Customers
- LanzaTech Global Inc. CEO Dr. Jennifer Holmgren featured on Water Tower Research Small-Cap Spotlight Podcast